| 000 | 01779 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250517144049.0 | ||
| 264 | 0 | _c20190107 | |
| 008 | 201901s 0 0 eng d | ||
| 022 | _a2151-4658 | ||
| 024 | 7 |
_a10.1002/acr.23242 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHermans, Job | |
| 245 | 0 | 0 |
_aCost-Utility Analysis of High Molecular Weight Hyaluronic Acid for Knee Osteoarthritis in Everyday Clinical Care in Patients at a Working Age: An Economic Evaluation of a Randomized Clinical Trial. _h[electronic resource] |
| 260 |
_bArthritis care & research _c01 2018 |
||
| 300 |
_a89-97 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 | _aDrug Costs |
| 650 | 0 | 4 | _aEfficiency |
| 650 | 0 | 4 |
_aEmployment _xeconomics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHealth Status |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyaluronic Acid _xeconomics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMolecular Weight |
| 650 | 0 | 4 |
_aOsteoarthritis, Knee _xdiagnosis |
| 650 | 0 | 4 | _aQuality-Adjusted Life Years |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aViscosupplements _xeconomics |
| 650 | 0 | 4 | _aWork Capacity Evaluation |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aReijman, Max | |
| 700 | 1 | _aGoossens, Lucas M A | |
| 700 | 1 | _aVerburg, Hennie | |
| 700 | 1 | _aBierma-Zeinstra, Sita M A | |
| 700 | 1 | _aKoopmanschap, Marc A | |
| 773 | 0 |
_tArthritis care & research _gvol. 70 _gno. 1 _gp. 89-97 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/acr.23242 _zAvailable from publisher's website |
| 999 |
_c26994098 _d26994098 |
||